These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


264 related items for PubMed ID: 15767330

  • 1. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.
    Su L, Zhou W, Park S, Wain JC, Lynch TJ, Liu G, Christiani DC.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330
    [Abstract] [Full Text] [Related]

  • 2. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y, Spitz MR, Lei L, Mills GB, Wu X.
    Cancer Res; 2001 Nov 01; 61(21):7825-9. PubMed ID: 11691799
    [Abstract] [Full Text] [Related]

  • 3. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
    Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G, Christiani DC.
    Carcinogenesis; 2006 May 01; 27(5):1024-9. PubMed ID: 16311244
    [Abstract] [Full Text] [Related]

  • 4. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y.
    Carcinogenesis; 2004 Dec 01; 25(12):2379-84. PubMed ID: 15319295
    [Abstract] [Full Text] [Related]

  • 5. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI, Tugcu V, Ozbek E, Ozbay B, Simsek A, Koksal V.
    BJU Int; 2008 Feb 01; 101(4):503-7. PubMed ID: 17986285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S, Wang Y, Zhang JH, Jin X, Fang SM, Li Y.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep 01; 40(9):601-4. PubMed ID: 16202315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM, Jin X, Li Y, Wang R, Guo W, Wang N, Zhang JH.
    Ai Zheng; 2005 Mar 01; 24(3):305-10. PubMed ID: 15757531
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R.
    Clin Cancer Res; 2002 Dec 01; 8(12):3820-3. PubMed ID: 12473595
    [Abstract] [Full Text] [Related]

  • 20. DHPLC analysis of the matrix metalloproteinase-1 promoter 1G/2G polymorphism that can be easily used to screen large population.
    Xu E, Lai M, Lv B, Xing X, Huang Q, Ma Y, Wang W.
    J Biochem Biophys Methods; 2005 Jun 30; 63(3):222-7. PubMed ID: 15939478
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.